Titanium dioxide (TiO 2 ) is widely used as an inorganic UV-filter in cosmetic products; however, it has been classified as possibly carcinogenic to humans. While numerous studies demonstrated cytotoxic and genotoxic effects of nano-sized TiO 2 in different cell lines, including human skin cells, studies investigating the effects of micro-TiO 2 on human keratinocytes and melanocytes, in healthy and cancer cells, are scarce. Adenosine triphosphate (ATP) binding cassette subfamily B member 5 (ABCB5) is a plasma membrane protein known for its role in the tumorigenicity, progression, and recurrence of melanoma. Here, we investigated the effect of micro-TiO 2 (average particle size ≤5 µm) on the metabolic activity, cytotoxicity and ABCB5 mRNA expression in metastatic melanoma cells. Metastatic melanoma cell line WM-266-4 was treated with different concentrations of micro-TiO 2 for different incubation times to obtain dose-and time-dependent responses. Untreated WM-266-4 cells, cultured under the same conditions, were used as control. The cell metabolic activity was determined by MTT assay. Cytotoxicity of micro-TiO 2 was analyzed by lactate dehydrogenase (LDH) cytotoxicity assay. The ABCB5 mRNA expression in melanoma cells was analyzed using quantitative reverse transcription polymerase chain reaction (RT-qPCR). After 120 hours of exposure to micro-TiO 2 the metabolic activity of melanoma cells decreased, especially at the two highest micro-TiO 2 concentrations. Comparably, the cytotoxicity of micro-TiO 2 on melanoma cells increased after 48 and 120 hours of exposure, in a time-dependent manner. The ABCB5 mRNA expression in micro-TiO 2 -treated melanoma cells also decreased significantly after 24 and 48 hours, in a time-dependent manner. Overall, our results suggest inhibitory effects of microTiO 2 on the metabolic activity and ABCB5 mRNA expression in metastatic melanoma cells, indicating its potential use as an anticancer agent.
INTRODUCTION
The use of topical sunscreens and other personal care products containing UV filters has been increasing, due to an increase in public awareness of the harmful effects of solar ultraviolet (UV) radiation [1] [2] [3] [4] . Broad spectrum protection from UVA and UVB rays and regular application of sunscreens in sufficient amounts (e.g., 2 mg/cm 2 of skin surface) have proven to be useful in the prevention of actinic keratosis (AK), squamous cell carcinomas (SCCs) and skin ageing; however, a significant benefit of regular sunscreen use in the primary prevention of basal cell carcinoma (BCC) and melanoma has not yet been demonstrated [5, 6] . The active ingredients (UV filters) used in sunscreens have different absorption spectra and mechanism of action, and can be classified as organic (chemical) and inorganic (physical) filters. Inorganic sunscreens such as those based on zinc oxide (ZnO) and titanium dioxide (TiO 2 ) cover a wider spectral range compared to most of the organic sunscreens; however the cosmetic acceptability of inorganic UV filters is still inferior as they produce white coloration when applied to the skin [7] . To overcome the undesired effect (i.e. a white film on the skin) of the opaque sunscreen products, micro-sized inorganic UV filters have been increasingly replaced by the nano-sized filters [8] which, due to the very small size of particles, are transparent and thus provide improved aesthetic outcome [9] . Conventionally, particles that are less than 100 nm in size are classified as nanoparticles and those larger as microparticles [10] . Nanotechnology is considered to be the next logical step in science, nevertheless, the toxicological and environmental impact of nanoparticles is still the subject of considerable debate [11] . Thus, it is questionable whether the cosmetic acceptability of nano-sized UV One of the most widely used physical UVA and UVB filters is TiO 2 , which has three crystal structures, i.e., anatase, rutile and brookite. Its ability to block the UV radiation through scattering, reflecting and/or absorbing makes it a very effective active ingredient in sunscreen cosmetics, where it is used in concentrations up to 25% [12, 13] . However, the International Agency for Research of Cancer has classified TiO 2 as possibly carcinogenic to humans (Group 2B carcinogen) [14] . Furthermore, numerous in vitro studies showed that TiO 2 nanoparticles (nano-TiO 2 ) are able to induce cytotoxicity, reactive oxygen species (ROS), and genotoxicity in different cell lines [15] . For micro-sized TiO 2 (micro-TiO 2 ), an in vivo study showed that it could induce DNA damage and micronuclei in bone marrow cells, increase the mitotic index in forestomach and colon epithelia and the frequency of spermatids with two and more nuclei, in mice [16] . Another, in vitro, study showed that micro-TiO 2 was able to induce ROS formation and single-strand DNA breaks in human Caco-2 cells [17] . Nevertheless, more data is needed to make a final conclusion on the effect of micro-TiO 2 on human health.
A study investigating the effect of micronized TiO 2 (nanoparticles) on the barrier function of the human skin (epidermis) transplanted to immunodeficient mice showed that nano-TiO 2 does not penetrate through the intact epidermal barrier. On the other hand, when exposed directly, TiO 2 nanoparticles were able to affect the functional properties of epidermal and dermal cells in vitro [18] . In contrast, there is a lack of studies on the effect of micro-TiO 2 on human keratinocytes and melanocytes, both in healthy and cancer cells. To the best of our knowledge, no published in vitro or in vivo study has investigated the molecular effects of micro-TiO 2 on melanoma cells.
Adenosine triphosphate (ATP) binding cassette subfamily B member 5 (ABCB5) is a plasma membrane protein and the member of ABC transporter superfamily (subfamily B or MDR/ TAP [multidrug resistance/transporter associated with antigen processing]), encoded by the ABCB5 gene (chromosome 7p21.1) [19] . Tumor cells expressing ABCB5 may have properties of stem cells and a survival advantage compared to other cell (sub)populations in tumor microenvironment [20, 21] . The ABCB5 transmembrane protein plays an important role in the tumorigenic potential and metastatic disease progression of diverse human malignancies, including melanoma [22] . This leads to a relapse in patients with supposedly cured melanoma, even several years after the treatment with chemotherapy, radiotherapy or immunotherapy [21, 23, 24] . Generally, the treatment of metastatic melanoma represents a great clinical challenge, as the metastatic form is highly aggressive and resistant to conventional therapies, with an average survival time of 6-10 months [25, 26] .
This study aims to investigate the effect of micro-TiO 2 on the metabolic activity, cytotoxicity, and ABCB5 mRNA expression in WM-266-4 human metastatic melanoma cell line. ) and 0.02% MycoZap Plus-CL (Lonza, Portsmouth, NH, USA), and incubated at 37 °C, 5% CO 2 , ≥90% relative humidity (RH). The complete medium was replaced every 48 hours. When the culture became confluent, the cells were subcultivated by trypsinization using Detach kit (Catalog number C-41220, PromoCell, Heidelberg, Germany, EU) and replated.
MATERIALS AND METHODS

Cell
UV filter
TiO 2 in the rutile form and with an average particle size of ≤5 μm (micro-TiO 2 ) was purchased from Sigma-Aldrich, USA (AL-224227-5G). A 10 mg/mL stock solution of microTiO 2 was prepared and diluted with the EMEM (ATCC 
30-2003
TM ) based complete medium to make 250 µg/mL, 125 µg/mL, 100 µg/mL, 50 µg/mL, 20 µg/mL, 10 µg/mL, and 1 µg/mL concentrations of TiO 2 , which were then applied to WM-266-4 cells grown in 6-well, 24-well or 96-well culture plates.
MTT cell metabolic activity assay
The cells were plated at a density of 1 × 10 4 viable cells per well in 24-well culture plates and cultured for 24 hours in the EMEM-based complete medium to allow cell attachment.
To measure the cell metabolic activity, WM-266-4 cells were exposed to five selected concentrations of microTiO 2 (250, 100, 20, 10, and 1 µg/mL) and cultured for 8, 24, 48 and 120 hours. Control cells were cultured under the same conditions but without the addition of micro-TiO 2 . Afterwards, the MTT [3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide] assay was performed using the Colorimetric Cell Viability Kit IV (PromoKine, PromoCell, Heidelberg, Germany, EU), following the manufacturer' s instructions. The absorbance was measured at 570 nm and then the background absorbance (at 630 nm) was subtracted (OD570-OD630). All tests were performed in triplicates. The percentage of metabolically active cells was calculated with the following equation: ((OD570-OD630) test sample value/ (OD570-OD630) control value) × 100.
LDH cell cytotoxicity assay
The cells were plated at a density of 9 × 10 2 viable cells per well in 96-well culture plates and cultured for 24 hours in the EMEM-based complete medium to allow cell attachment. To evaluate the cytotoxicity of micro-TiO 2 in melanoma cells, WM-266-4 cells were exposed to five selected micro-TiO 2 concentrations (250, 100, 20, 10, and 1 µg/mL) and incubated for 48 and 120 hours. Then, the lactate dehydrogenase (LDH) assay using the LDH Cytotoxicity Kit II (PromoKine, PromoCell, Heidelberg, Germany, EU) was carried out, following the manufacturer' s instructions. All tests were performed in triplicates. The percentage of cytotoxicity was calculated with the following equation: ((Test Sample -Low Control)/ (High Control -Low Control)) × 100, where the cells grown in EMEM plus cell lysis solution represented high control and the cells grown in EMEM alone represented the low control.
RNA isolation and cDNA synthesis
The WM-266-4 cells were seeded at a density of 2 × 10 4 into 6-well culture plates and incubated overnight in the EMEM-based complete medium. Afterwards, the cells were treated with six different concentrations of microTiO 2 (250 µg/mL, 125 µg/mL, 50 µg/mL, 20 µg/mL, 10 µg/mL, and 1 µg/mL) and incubated for 2, 24 and 48 hours. The total RNA was isolated from the treated and control cells using High Pure RNA Isolation Kit (Cat. No. 11 828 665 001, Roche, Basel, Switzerland), following the manufacturer' s protocol. The concentration and purity of RNA were determined using the Thermo Scientific NanoDrop 2000c spectrophotometer (Thermo Fisher Scientific, MA, USA). The purified RNA was stored at -80°C. Reverse transcription (RT) into complementary DNA (cDNA) was performed using the Transcriptor Universal cDNA Master Kit (Cat. No. 05 893 151 001, Roche, Basel, Switzerland), following the manufacturer' s instructions.
Quantitative RT polymerase chain reaction (RT-qPCR)
RT-qPCR was used to determine the expression of the ABCB5 gene in control and treated WM-266-4 cells. The PCR reaction included 100 ng of cDNA, LC480 Probes Master (Roche) and RT Ready Designer/Catalog assays (Roche, Basel, Switzerland) and was carried out on the LightCycler480 system II real-time PCR device (Roche, Basel, Switzerland). The LDHA gene was used as an endogenous control. PCR amplification efficiency was determined from a standard curve using template dilutions of 1:1, 1:10, 1:100 and 1:1000 at the same PCR conditions. The PCR protocol included an initial pre-incubation step at 95 °C for 10 minutes, followed by 45 cycles of denaturation at 95 °C for 10 seconds, annealing at 60 °C for 30 seconds and elongation at 72 °C for 1 second; the final step was cooling at 40 °C for 30 seconds. The PCR efficiencies for the ABCB5 and LDHA genes were verified by generating standard curves. All reactions were run in triplicates. Relative changes in ABCB5 mRNA expression were determined by the 2 -∆∆Ct method, normalized to the reference LDHA gene.
Cell morphology
Changes in cell morphology were recorded with a digital camera (DFC365 FX Leica, Buffalo Grove, IL, USA) attached to an inverted microscope (DMI6000B, Leica).
Statistical analysis
Student' s t-test, one-way analysis of variance (ANOVA) and post-hoc Bonferroni tests were conducted using IBM SPSS Statistics for Windows, Version 20.0. (IBM Corp., Armonk, NY). The level of significance was set at p < 0.05. All values are expressed as mean ± standard error of the mean (SEM). Graphs were created with GraphPad Prism version 5.00 for Windows (GraphPad Software, La Jolla, CA, USA).
RESULTS
The effect of micro-TiO 2 on the metabolic activity of metastatic melanoma cells
The MTT assay showed that after 24 hours of exposure to micro-TiO 2 , the metabolic activity of WM-266-4 cells significantly increased at all tested concentrations (the mean metabolic activity was 174.8% ± 25.0%), compared to untreated control cells at the same incubation time (p = 0.030). However, after 120 hours of exposure, a marked decrease in the cell metabolic activity and viability was observed, especially at the two highest micro-TiO 2 concentrations; i.e., at 250 µg/ml micro-TiO 2 the cell metabolic activity was 51.5% ± 9.2% and at 100 µg/ml it was 64.5% ± 0.7% (p = 0.004). Dose-and time-dependent curves of the metabolic activity of micro-TiO 2 -treated WM-266-4 cells in relation to untreated control cells are shown in Figure 1 .
Cytotoxic effects of micro-TiO 2 on metastatic melanoma cells
Using the LDH assay, we investigated whether the decrease in metabolic activity of WM-266-4 cells, observed after longer exposure to micro-TiO 2 , was related to the cytotoxic effects of TiO 2 . After 48 hours of micro-TiO 2 exposure, we observed a significant cytotoxicity on WM-266-4 cells compared to control (p = 0.012). The percentage of cytotoxicity in WM-266-4 cells after 48 hours of exposure was 22.1% ± 0.4% at 250 µg/ml micro-TiO 2 and 15.2% ± 1.6% at 100 µg/ ml micro-TiO 2 (Table 1) . After 120 hours of exposure, the rate of cytotoxicity significantly increased (p = 0.047), to 97.0% ± 2.8% at 250 µg/ml and 60.0% ± 2.8% at 100 µg/ml micro-TiO 2 (Table 1 ).
Microscopic observations of metastatic melanoma cells after exposure to micro-TiO 2 Micro-TiO 2 tended to aggregate close to WM-266-4 cells in every well and arrange into spherical assemblies at the cell surface (Figure 2A-C) . After 24 hours of exposure of metastatic melanoma cells to micro-TiO 2 , we observed altered size and shape in some cells (Figure 2D-E) . After 48 hours, a few spindle cells and numerous melanospheres were observed, and some of these cells were with granular cytoplasm. Following 120 hours of exposure to the two highest concentrations of microTiO 2 (100 and 250 µg/ml), the number of WM-266-4 cells markedly decreased compared to cells treated with a lower concentration of micro-TiO 2 (i.e., 20 µg/ml) and untreated control cells. Also, after 120 hours of exposure more melanoma cells with granular cytoplasm were observed. At lower concentrations of micro-TiO 2 , there was no significant change in the number of WM-266-4 cells compared to untreated control cells (Figure 3 ).
Micro-TiO 2 progressively decreased the ABCB5 mRNA expression in metastatic melanoma cells
The expression of ABCB5 gene was significantly lower in WM-266-4 cells exposed to micro-TiO 2 for 24 and 48 hours compared to the untreated control cells and compared to WM-266-4 cells exposed to micro-TiO 2 for 2 hours [p = 0.002] (Figure 4 ).
DISCUSSION
Previously, we showed that ABCB5 mRNA expression significantly increases in metastatic melanoma cells exposed to the UV filters octocrylene (OCT) and nano-TiO 2 , in a time-dependent manner. This result indicates that the two UV filters may promote tumor invasion, progression and recurrence; therefore, patients diagnosed with metastatic melanoma should avoid products containing nano-TiO 2 and OCT [27, 28] . However, nano-sized TiO 2 and micro-sized TiO 2 particles can differ in their effects and should not be treated in the same way. For example, nano-sized TiO 2 powders have FIGURE 1. Metabolic activity of micro-TiO 2 -treated WM-266-4 metastatic melanoma cells at selected micro-TiO 2 concentrations and exposure times in relation to untreated WM-266-4 cells (control), as evaluated by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyltetrazolium bromide (MTT) assay. All values are expressed as mean ± standard error of the mean (SEM). After 24 hours of exposure to micro-TiO 2 , the metabolic activity of WM-266-4 cells significantly increased at all tested concentrations (the mean metabolic activity was 174.8% ± 25.0%), compared to untreated control cells at the same incubation time (p = 0.030). After 120 hours of exposure, a marked decrease in the cell metabolic activity and viability was observed, especially at the two highest micro-TiO 2 concentrations; i.e. at 250 µg/ml micro-TiO 2 the cell metabolic activity was 51.5% ± 9.2% and at 100 µg/ml it was 64.5% ± 0.7% (p = 0.004). 
cells (D-E).
A B C D E F significantly higher specific surface area and may exhibit physical and chemical properties different from those of microparticles [29] .
In the present study, we investigated the effect of microTiO 2 on the metabolic activity, cytotoxicity, and ABCB5 mRNA expression in metastatic melanoma cells. The tested concentrations of micro-TiO 2 were selected based on our previous studies on nano-TiO 2 and OCT [27, 28] , as specific studies on the effects of micro-TiO 2 on human skin cells are still scarce. Similar TiO 2 concentrations were also used in nanoTiO 2 penetration and toxicity studies on various cells, including keratinocytes [18, 30, 31] , and in a study investigating the effect of micro-TiO 2 on human leukocytes and fibroblasts [32] . In the current study, we were interested only in the basic function of micro-TiO 2 in WM-266-4 cells and hence we did not expose the treated melanoma cells to UV light.
Our MTT results showed that, until 24 hours of incubation, the metabolic activity of metastatic melanoma cells increased with increased time of exposure to micro-TiO 2 , in a concentration-independent manner. After 120 hours of incubation, a marked decrease in the cell metabolic activity and viability was observed, which was especially obvious at the two highest concentrations of micro-TiO 2 [100 and 250 µg/ml] (Figure 1) . These results were consistent with our LDH results (Table 1) , i.e., after 48 hours of micro-TiO 2 exposure, we observed a significant cytotoxicity on WM-266-4 cells. The limitation of the LDH and most other cytotoxicity assays is that they are based on the premise that due to highly compromised cellular membranes in dying cells they release their cytoplasmic components, including LDH, into the culture medium. However, because the loss of membrane integrity often occurs quite late in apoptosis and necrosis, we suspect that the cytotoxic activity of micro-TiO 2 observed in our study is even underestimated. Our microscopic observations were also consistent with the LDH results as we observed only a few spindle cells and numerous melanospheres after 48 hours of exposure of metastatic melanoma cells to micro-TiO 2 , and some of these cells were with granular cytoplasm. After 120 hours of exposure to micro-TiO 2 even more melanoma cells with granular cytoplasm were observed (Figure 3 ). Micro-TiO 2 particles were evenly distributed over the area without cells, but tended to aggregate and arrange into spherical assemblies at the cell surface (Figure 2A-C) . Following 24 hours of exposure to microTiO 2 , some cells became larger than others and their shape changed ( Figure 2D-F) . This phenomenon was observed after 24 and 48 hours of micro-TiO 2 exposure when the metabolic activity of treated melanoma cells was higher than that of untreated control cells. These TiO 2 -treated melanoma cells did not have the shape of melanospheres nor did they have microscopic characteristics of cellular cannibalism, such as those previously observed in metastatic melanoma cells exposed to OCT after a decrease in their metabolic activity [27] .
Using qRT-PCR we analyzed ABCB5 mRNA expression in metastatic melanoma cells treated with micro-TiO 2 . Figure 4 provides an overview of the results, which indicate that different concentrations of micro-TiO 2 within our tested concentration range significantly decrease the expression of the ABCB5 mRNA in metastatic melanoma cells, in a time-dependent manner. The ABCB5 gene expression was lower in cells exposed to micro-TiO 2 for 24 hours and especially in cells exposed for 48 hours, compared to the cells exposed to microTiO 2 for 2 hours. Because the LDH assay showed very high cytotoxicity of micro-TiO 2 on melanoma cells after 120 hours of exposure, especially at the two highest concentrations of micro-TiO 2 , we did not analyze the expression of ABCB5 gene at longer incubation time points, as the insufficient number of cells could have affected the accuracy of the results.
Taken together, our results indicate inhibitory effects of micro-TiO 2 on the metabolic activity and ABCB5 mRNA expression in metastatic melanoma cells. Due to the known cellular roles of the ABCB5 protein, it can be assumed that metastatic melanoma cells which survive exposure to microTiO 2 are less invasive and less resistant, compared to other melanoma cells or control cells. As such, micro-TiO 2 may be an effective anticancer agent. Our results suggest that, in UV protection cosmetics, it might be safer to use micro-TiO 2 rather than nano-TiO 2 . Some authors even consider the introduction of innovative technologies such as nanotechnology to be a societal experiment, and argue that the marketing of sunscreens containing nano-TiO 2 is ethically undesirable [33] .
Further studies are necessary to confirm our results. The safety profile of micro-TiO 2 should be first established with normal melanocytes (primary culture) and melanoma cells from the primary tumor site, before any definitive conclusions. In addition, it would be informative to investigate the effect of micro-TiO 2 on other potential markers of melanoma cells, i.e. nerve growth factor receptor (NGFR or CD271), aldehyde dehydrogenases (ALDH), receptor activator of nuclear factor κ B (RANK), melanoma-associated chondroitin sulfate proteoglycan (MCSP), and melanoma cell adhesion molecule (MCAM or CD146) [34] [35] [36] [37] . One of the most important goals in melanoma research is to improve the prevention and treatment strategies for this aggressive form of cancer, and the results of our study may serve as a starting point for future studies in this promising area of research.
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